Celadon Pharmaceuticals finance chief to step down

Celadon Pharmaceuticals announced on Monday that Jonathan Turner, its chief financial officer, was stepping down.

The AIM-traded firm said Turner would vacate from his position on the board on 27 December.

It said it was starting the search for Turner’s successor immediately, with an update to be provided once a new CFO had been appointed.

At 1507 BST, shares in Celadon Pharmaceuticals were down 20.55% at 29p.

Reporting by Josh White for Sharecast.com.